Warning letter
MSM Nutraceuticals, LLC dba MSM Health Solutions: warning letter of Oct 24, 2019
FDA warning letter 584018 · Division of Pharmaceutical Quality Operations IV
Key facts
| Reference number | 584018 |
|---|---|
| Company | MSM Nutraceuticals, LLC dba MSM Health Solutions |
| Subject | CGMP/Finished Pharmaceuticals/Adulterated |
| Issue date | Oct 24, 2019 |
| Posted date | Nov 12, 2019 |
| Issuing office | Division of Pharmaceutical Quality Operations IV |
| Product type | Drugs |
| CFR sections cited | 211.165(a), 211.137(a), 201.128, 211.34, 330.1, 201.66(b)(2), 211.84(d)(1), 211.100(a) |
| Inspection city | Phoenix |
| Inspection ZIP | 85027-1245 |
| Inspection start date | Apr 30, 2019 |
| Letter on fda.gov | fda.gov |
At a glance
- 1–9 CFR sections cited
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: